Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001047469-14-001422
Filing Date
2014-02-27
Accepted
2014-02-27 07:21:49
Documents
26
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-KT a2218462z10-kt.htm 10-KT 2465584
2 EX-10.74 a2218462zex-10_74.htm EX-10.74 66456
3 EX-10.75 a2218462zex-10_75.htm EX-10.75 11709
4 EX-10.76 a2218462zex-10_76.htm EX-10.76 15209
5 EX-10.77 a2218462zex-10_77.htm EX-10.77 20147
6 EX-10.78 a2218462zex-10_78.htm EX-10.78 18448
7 EX-10.79 a2218462zex-10_79.htm EX-10.79 17594
8 EX-10.80 a2218462zex-10_80.htm EX-10.80 26568
9 EX-21.1 a2218462zex-21_1.htm EX-21.1 6370
10 EX-23.1 a2218462zex-23_1.htm EX-23.1 2846
11 EX-31.1 a2218462zex-31_1.htm EX-31.1 8033
12 EX-31.2 a2218462zex-31_2.htm EX-31.2 8061
13 EX-32.1 a2218462zex-32_1.htm EX-32.1 5198
20 G440989.JPG g440989.jpg GRAPHIC 54659
21 G263162KKI001.JPG g263162kki001.jpg GRAPHIC 2037
22 G263162KMI001.JPG g263162kmi001.jpg GRAPHIC 2037
23 G263162KOI001.JPG g263162koi001.jpg GRAPHIC 1973
24 G263162KQI001.JPG g263162kqi001.jpg GRAPHIC 1973
25 G263162KSI001.JPG g263162ksi001.jpg GRAPHIC 2035
26 G263162KUI001.JPG g263162kui001.jpg GRAPHIC 1969
  Complete submission text file 0001047469-14-001422.txt   16112225

Data Files

Seq Description Document Type Size
14 EX-101.INS alks-20131231.xml EX-101.INS 2294855
15 EX-101.SCH alks-20131231.xsd EX-101.SCH 96747
16 EX-101.CAL alks-20131231_cal.xml EX-101.CAL 137468
17 EX-101.LAB alks-20131231_lab.xml EX-101.LAB 1840609
18 EX-101.PRE alks-20131231_pre.xml EX-101.PRE 889599
19 EX-101.DEF alks-20131231_def.xml EX-101.DEF 568538
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-35299 | Film No.: 14646679
SIC: 2834 Pharmaceutical Preparations